OBJECTIVES: Minimally invasive extracorporeal circuits (MiECCs) aim at the preservation of physiologic reserves, the impact of which is expected to be most evident in patients in whom these are depleted. In this context, octogenarians present a subpopulation of specific interest.
Impact of minimally invasive extracorporeal circuits on octogenarians undergoing coronary artery bypass grafting.
Have we been looking in the wrong direction? † 
INTRODUCTION
The term minimally invasive extracorporeal circuits (MiECCs) was recently introduced [1] to emphasize the role these circuits play in preserving homeostasis during cardiopulmonary bypass. This concept ultimately results in the preservation of the physiologic reserves, which the patients need to cope with the stresses of major surgery and to overcome the associated risks with a minimum of morbidity. The ideal result being an optimum outcome, comprising a freedom of all complications and transfusions, which is most probably a paramount determinant of a postoperative improvement in quality of life. Considering the above mentioned, we anticipated that patients who are most likely to benefit from the use of an MiECC would be those with significantly depleted physiologic reserves. In that context, octogenarians present a subpopulation of patients of particular interest.
MATERIALS AND METHODS
Based on an extensive experience with MiECC (6800 procedures; 40% of all cardiac operations utilizing cardiopulmonary bypass between 2002 and 2016), we conducted a retrospective singlecentre analysis of 324 consecutive octogenarians who underwent coronary artery bypass grafting (CABG) in our institution from January 2003 to December 2010. Their baseline characteristics are listed in Table 1 . Noteworthy is a logistic EuroSCORE I of 17 ± 14% and a high incidence of urgent/emergent procedures with 60% and 7%, respectively. †Presented at the 2nd International Minimal Invasive Extra-Corporeal Technologies Symposium, Athens, Greece, 9-11 June 2016. This time period was chosen as we anticipated that it would reflect a timeline where the distribution of patients to both ECCs would have been equal and as our initial learning curve with MiECC had been achieved by 2003. Furthermore, our transfusion triggers in that patient population shifted after 2010 from a liberal strategy with a transfusion trigger of 10 g/dl of haemoglobin to a more restrictive one (rough transfusion trigger of 8 g/dl).
The local ethics committee approved the study (Medizinische Hochschule Hannover-approval 2551-2015). Individual patients consent was waived because of the study's retrospective design and data collection from routine care. Excluded were patients who underwent redo surgery or concomitant procedures other than carotid artery endarterectomy or a maze procedure.
Procedural strategy
Surgery was performed through a median sternotomy. After heparinization (3 mg kg -1 ) with a target-activated clotting time of 480 s (measured at initial dose and every 20 min thereafter), cardiopulmonary bypass was established with an arterial cannula in the ascending aorta and a 2-stage venous cannula was introduced via the right atrium. Flow rates of 2.4 cardiac index (CI) Â body surface area (BSA) were aspired. All circuits were primed with crystalloid solution with no additives, as retrograde autologous priming was employed in all patients. Myocardial protection was achieved with intermittent warm-blood cardioplegia in the MiECC group and cold crystalloid Bretschneider cardioplegia in the conventional ECC group. Cardiotomy suction was used in the conventional ECC, while a cell saver was used in the MiECC. At the end of cardiopulmonary bypass, the patient s blood was re-transfused by antegrade washout in all patients. At the end of the operation, heparin was antagonized with protamine sulphate.
Anaesthesiologists and perfusionists were the same for both groups as was the anesthetic management.
Data collection and statistical evaluation
Patient data were collected prospectively and retrospectively extracted from the clinics database and from medical records. Variables were defined according to the European System of Cardiac Operative Risk Evaluation (EuroSCORE) [2] .
The SPSS version 22.0 statistical software was employed (IBM Corporation, Armonk, NY, USA). Results are reported as mean ± standard deviation or percentages as appropriate. Continuous variables were compared by unpaired Student's t-test (the paired Student's t-test was used for propensity-matched continuous variables), while the v 2 test and Fisher's exact test were used to compare discrete variables. For all tests, a P-value of <0.05 was deemed statistically significant.
As the patients were not randomized to either circuit, to reduce the confounding effect of other variables, a propensity score analysis was performed by means of a multivariable logistic regression model for the combined cohort of 324 patients.
In this model, the type of circuit served as a dependent variable and all relevant baseline demographic characteristics (Table 1) served as covariates to calculate the propensity score for each patient individually. Using these propensity scores, patients who received an MiECC were matched to patients who received a conventional ECC. A propensity score difference of 0.15 was used as a maximum caliper width for matching the 2 treatment groups.
RESULTS
The procedural characteristics of the 324 patients showed that they received 3.6 ± 0.9 grafts during a cross-clamping time of 57 ± 45 min and an ECC time of 87 ± 22 min. Their overall 30-day mortality was 6%, while the incidence of postoperative stroke equalled 3.7%.
Based on the type of circuit employed during the procedure, the patients were divided into 2 groups: an MiECC group of 169 patients (mainly the RocSafe system, Terumo Corporation, Tokyo, Japan but also the CorX system, CardioVention, Santa Clara, CA, USA and the ECC.O system, Sorin Group, Mirandola, Italy) and a conventional ECC group of 155 patients. Demographics, procedural characteristics and postoperative results of both groups are presented in Tables 2 and 3 . They demonstrate that the patients in the MiECC group were older (83 ± 2 vs 82 ± 2 years; P = 0.001), had a higher incidence of renal dysfunction (8% vs 3%; P = 0.04), a moderately reduced left ventricular function (43 vs 33%; P = 0.07) and a lower incidence of unstable angina (20% vs 28%; P = 0.06). However, the postoperative results show that the incidence of cardiopulmonary complications with postoperative low cardiac output (0% vs 5%; P = 0.002), need for intra-aortic balloon counter pulsation (0% vs 3%; P = 0.02) and reintubation for respiratory insufficiency (1% vs 5%; P = 0.03) were all in favour of the MiECC group. Furthermore, the 30-day mortality was in favour of the minimally invasive concept (3.5% vs 9%; P = 0.04).
Following propensity score matching that yielded 126 patients in each group (Tables 4 and 5 ) the incidence of postoperative 
23 ( low cardiac output with (0% vs 6%; P = 0.01), the transfusion rate of packed red blood cells (70% vs 83%; P = 0.02), the amount of red blood cells transfused per patient (2.2 ± 2.3 vs 3.4 ± 3.3 units per patient; P = 0.001) ( Fig. 1 ) and the 30-day mortality (2.4% vs 9.5%; P = 0.02) remained statistically significant in favour of the minimally invasive concept. A timeline analysis ( Fig. 2) shows that throughout the time period from 2003 until 2010 there was a shift in which the minimally invasive concept gradually replaced the conventional one, the yearly mortality rates, however, rule out a time bias. Furthermore, the overall mortality during the first half of the study amounted to 10 of 169 patients, thus nearly equalling that of the second half namely 10 of 155 patients.
DISCUSSION
Although prospective randomized trials in the field of MiECC are plentiful [1, 3] , so far a mortality benefit has only been reported in their meta-analyses [3, 4] . This observation is owed foremost to the low numbers of patients included in these studies, with only 2 studies to date including 200 patients or more in each group [5, 6] ; in addition, the patients included in these studies were mostly low-risk patients undergoing relatively simple cardiac procedures. In fact, even the meta-analyses have not been consistent in terms of a mortality benefit [3, 4, [7] [8] [9] .
Fortunately, the mortality and morbidity after CABG in the general population is relatively small. Advanced age, although by itself no disease entity, octogenarians have depleted physiologic reserves in addition to a high incidence of morbidity [10] . They therefore serve as a magnifying lens that highlights the impact MiECCs may have in preserving physiologic reserves. Hence, if we are to expect differences in mortality rates, looking into the results of a small number of low-risk patients undergoing simple cardiac procedures is most probably the wrong direction to look for.
Looking at the general morbidity and mortality rates in the whole collective, we find that these compare well to those of similar studies [10] [11] [12] [13] . In 2005, Scott et al. [10] retrospectively examined resource utilization and postoperative outcome in 155 consecutive octogenarians undergoing CABG in their institution over a period of 3 years. They reported on a 30-day postoperative mortality rate of 9.0% and a transfusion requirement of 88.4%. Comparing those patients to 1591 younger ones undergoing CABG during the same time period they concluded that age 80 years or older was significantly associated with outcome and was an independent predictor of increased resource utilization and postoperative mortality and morbidity. Raja et al. in 2013 [12] compared the outcomes of 290 octogenarians undergoing on-pump and off-pump CABG in their hospital from 2000 to 2010, which is similar to the time period as our population and with a mean age of 82 ± 2.0 years which is again similar to our study. They reported on an in-hospital mortality of 6.0% vs 11.0% (overall 7.2%) in favour of the off-pump group. With an overall mortality rate of 6.2% (3.5% vs 9.0% in the unmatched groups), our results are quite similar, although our patient collective had a higher incidence of diabetes, hypertension, chronic obstructive pulmonary disease, peripheral vascular disease, triple vessel disease, urgent interventions, myocardial dysfunction and a higher logistic EuroSCORE. Recently, Altarabsheh et al. published a meta-analysis [13] comprising 18 000 patients from publications published between 2000 and 2013 in which they compared the results of on-pump and off-pump CABG in octogenarians. They reported that early mortality, which was defined as postoperative, in-hospital or 30-day mortality, was similar with 4.6 in the on-pump and 5.2% in the off-pump group. Although our overall mortality with 6.2% was higher, 67.3% of our surgeries were non-elective, while those in the meta-analysis were much lower with 43% in the on-pump and 33% in the off-pump group.
The GOPCABE study group reported on one of the largest prospective randomized studies of off-pump versus on-pump CABG in over 2500 elective elderly patients (75 years or older) in 2015 [11] . The surgeons in that study were all highly experienced, the patients were younger, all were elective and their mean logistic EuroSCORE was 8.3 ± 4.0 and 8.2 ± 6.6 (vs 15 ± 12 in our study). These differences explain why our general population had a higher mortality of 6.2% (5% excluding emergent cases) in comparison with the GOPCABE study (2.6 for the off-pump versus 2.8 for the on-pump group) and a higher incidence of stroke 3.7% (2.2% vs 2.7% GOPCABE), however, does not account for a similar incidence of myocardial infarction 1.9% (1.5 vs 1.7% GOPCABE) and new onset renal replacement therapy 3.1% (2.4% vs 3.1% GOPCABE), keeping in mind that the results of our MiECC population were 3.6% for mortality and 0.6% for myocardial infarction.
Looking at the risk profile of both groups, we found that almost all factors that showed a significant difference in distribution namely age, higher incidence of impaired renal function and higher incidence of moderate left ventricular dysfunction were all lower in the conventional circuit, the incidence of unstable angina being the only risk factor in favour of the MiECC group. We were thus surprised that the minimally invasive concept compensated for these risks and led to significant differences in outcome in favour of the MiECC. In an attempt to rule out the role of the individual surgeons and the timeline bias, we further scrutinized these 2 factors. Plotting the yearly distribution of MiECC to conventional extracorporeal circuit (CECC) confirmed that the incidence of the former increased over the years, while the numbers of CECC were on the fall with a nearly 1:1 distribution in 2006. However, looking at the development of the mortality rates during the time period showed that there was no relation between both, meaning that other factors that might not be accounted for in our statistical analysis and that might have had a positive impact over time seemingly had no effect on our results. An analysis 
20 (16) 14 (11) 0.3
MiECC: minimally invasive extracorporeal circulation; CECC: conventional extracorporeal circuit; ICU: intensive care unit; IABP: intra-aortic balloon pump; GIT: gastrointestinal tract. Definitions for myocardial infarction, low cardiac output, stroke and optimum outcome are available in the Supplementary Material. of the performing surgeons (Fig. 3) shows that most were equally presented in both groups, a fact that can be mainly attributed to a lack of a sufficient number of MiECC systems in our institution during that time period, making the choice of the circuit primarily dependent on availability rather than a surgeon's preference. In fact, only 5 surgeons had a statistically significant higher likelihood of performing with one circuit rather than the other (this remains significant only for a single surgeon after propensity matching). However, the mortality rates would remain fairly constant after excluding the patients of those 5 surgeons from the analysis. In a further attempt at equality of risk and because the methodology is finding a high acceptance in the scientific community, at present we matched the patients by propensity scoring, which further confirmed a statistically significant lower mortality among the MiECC patients. The fact that different types of cardioplegia were used in both groups is most probably the biggest leanness of this study but is a shortcoming of almost all retrospective studies in this field. At the same time, we have found no study in the literature showing a mortality difference in relation to warm intermittent blood cardioplegia compared with cold crystalloid cardioplegia in CABG in a group size similar to ours. In other words, even if it makes a difference, its influence on our sample size should be negligible. Noteworthy, the largest randomized controlled trial [14] (1440 consecutive CABG patients) comparing blood cardioplegia to crystalloid cardioplegia has found no significant differences in postoperative left ventricular ejection fraction, spontaneous sinus rhythm after aortic declamping, use of inotropic drugs or intraaortic balloon pumping, perioperative myocardial infarction or mortality between both groups. Also, in subgroups of patients at higher operative risk (female sex, age >70 years, unstable angina, diabetes, emergency operation, ejection fraction <0.50, crossclamping time >50 min and EuroSCORE >4), no statistically significant differences could be demonstrated between the groups Similarly de Jonge et al. [15] compared crystalloid cardioplegia to intermittent warm blood cardioplegia in 2585 matched patients who underwent CABG. They demonstrated that blood cardioplegia was an independent risk factor for elevated creatine kinase MB levels but that the type of cardioplegia had no significant influence on clinical outcome.
The lower incidence of low cardiac output (0 vs 5.6% P = 0.01 matched) and need for intra-aortic pump counter pulsation (0 vs 4% P = 0.06 matched) in the MiECC group are consistent with the findings of other studies [4, 6, [16] [17] [18] . Hence Remadi et al. [6] described a reduction in the incidence of low cardiac output in association with MiECC (0.66% vs 4% P = <0.001) in a prospective randomized study on elective CABG patients, however, their postoperative use of an intra-aortic balloon pump did not show a significant difference. They also found a significant reduction in the incidence of postoperative low cardiac output in association with MiECC use in aortic valve replacement (AVR) in another prospective randomized trial [16] . Anastasiadis et al. [18] reported on a significant lower incidence of intra-aortic balloon pump use in a prospective randomized trial in CABG and confirmed a significant reduction in the incidence of low cardiac output in a meta-analysis they published in 2013 [4] . Both effects can be seen as the clinical reflection of a better myocardial preservation seen in conjunction with MiECC as has been described in many trials [5, 17, 19, 20] .
Postoperative need for dialysis in our study was similar in both groups, however less severe forms of renal damage were not looked for, as the patient numbers in respect to the retrospective nature of our analysis would have been too low. Likewise, a recently published meta-analysis of 24 randomized controlled trials failed to demonstrate a reduced incidence of postoperative renal failure in association with MiECCs [4] . However, comparing the incidence of postoperative dialysis in our population to that of similar studies shows that Raja et al. [12] reported on a postoperative need for haemofiltration of 9.9% vs 12.7% in favour of offpump CABG in comparison with on-pump CABG, while the incidence in our groups was much lower with 3.0 vs 3.2% (unmatched MiECC vs CECC). Again our results are comparable to those of the GOPCABE trial [11] , where the incidence of new renal replacement-therapy was 2.4% off-pump vs 3.1% on-pump, although their patients were younger with a lower incidence of moderate left ventricular dysfunction 30.7 vs 28.3% (38% in our general population) and a lower incidence of creatinine level exceeding 2.3 mg/dl preoperatively, namely 2.2% in both groups (5.2% in our general population).
Limitations
As always, the retrospective nature of this study compromises its value. However, we have tried to overcome this shortcoming by propensity score matching. Furthermore, the difference in the type of cardioplegia used for both groups is another limitation that we have already elaborated on in the discussion.
CONCLUSION
We believe that this study supports the notion that the issue with these modern perfusion circuits is not merely one of miniaturization but truly one of minimal invasiveness, as preserving physiology plays a major role in patient outcome.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
Conflict of interest: none declared. Mortality in relation to the performing surgeon and the circuit employed. Asterisk marks the surgeons with a statistically significant higher tendency of utilizing one circuit or the other. Excluding those from the analysis, however, does not affect the mortality rates (3 of 104 for MiECC and 9 of 103 for CECC). Following propensity matching, this tendency remained significant only for surgeon A, which again has no effect on the significance of the mortality rates. MiECC: minimally invasive extracorporeal circuit.
